Malvern, Pennsylvania-based VenatoRx Pharmaceuticals, an antibiotics developer, has raised $42 million in Series B financing. Versant Ventures led the round with participation from Abingworth and Foresite Capital.
Source: Press Release
Malvern, Pennsylvania-based VenatoRx Pharmaceuticals, an antibiotics developer, has raised $42 million in Series B financing. Versant Ventures led the round with participation from Abingworth and Foresite Capital.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: